The Society of Thoracic Surgeons/Society of Cardiovascular Anesthesiologists/American Society of Extracorporeal Technology Clinical Practice Guidelines for the Prevention of Adult Cardiac Surgery-Associated Acute Kidney Injury

Jeremiah R. Brown, Linda Shore-Lesserson, Amanda A. Fox, Linda B. Mongero, Kevin W. Lobdell, Scott A. Lemaire, Filip M.J.J. De Somer, Moritz Wyler Von Ballmoos, Viachaslau Barodka, Rakesh C. Arora, Scott Firestone, Richard Solomon, Chirag R. Parikh, Kenneth G. Shann, John Hammon, Robert A. Baker

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
13 Downloads (Pure)

Abstract

Executive summary

1. In adult cardiac surgery with cardiopulmonary bypass (CPB), avoiding hyperthermic perfusion (.37C) is recommended to reduce the risk of cardiac surgeryassociated acute kidney injury (CSA-AKI). (Class of Recommendation: I, Level of Evidence: B-R)

2. In adult cardiac surgery with CPB, a goal-directed oxygen delivery strategy is recommended to reduce the risk of CSA-AKI. (Class of Recommendation: I, Level
of Evidence: B-R)

3. In adult cardiac surgery with CPB, it is reasonable to adopt the Kidney Disease Improving Global Outcomes (KDIGO) practice guidelines for patients at high risk of AKI to reduce the risk of CSA-AKI. (Class of Recommendation IIA; Level of Evidence B-R)

4. In adult cardiac surgery with CPB, fenoldopam may be reasonable to reduce the risk of CSA-AKI, as long as hypotension is avoided. (Class of Recommendation: IIB, Level of Evidence: B-R)

5. In adult cardiac surgery with CPB, it might be reasonable to use minimally invasive extracorporeal circulation (MiECC) techniques to reduce the risk of CSA-AKI. (Class of Recommendation: IIB, Level of Evidence: B-R)

6. In adult cardiac surgery with CPB, dopamine infusion alone, during CPB and the perioperative period, is not recommended to reduce the risk of CSA-AKI. (Class of Recommendation III: No Benefit, Level of Evidence: A)

7. In adult cardiac surgery with CPB, mannitol is not recommended to reduce the risk of CSA-AKI. (Class of Recommendation III: No Benefit, Level of Evidence: B-R)
Original languageEnglish
Pages (from-to)267-290
Number of pages24
JournalJournal of ExtraCorporeal Technology
Volume54
Issue number4
DOIs
Publication statusPublished - Dec 2022

Keywords

  • cardiac disease
  • comorbidities
  • kidney disease
  • guidelines

Fingerprint

Dive into the research topics of 'The Society of Thoracic Surgeons/Society of Cardiovascular Anesthesiologists/American Society of Extracorporeal Technology Clinical Practice Guidelines for the Prevention of Adult Cardiac Surgery-Associated Acute Kidney Injury'. Together they form a unique fingerprint.

Cite this